1Samin K, Annapooma K, Jonathan D,ef al. Cardioprotective effect of priorbeta-blockers therapy in reducing creatine kinase-MB elevation after coro-nary intervation[ J]. Circulation,2000;102:166-72.
2Viskin S,Kitzis I,Lev E,et al. Treatment with beta-adrenergic blockingagents after myocardial infarction from randomized trial to clinical prac-tice[J]. J Am Coll Cardiol, 1995;25;1327-32.
3Yusuf S, Peto R, Lewis ] yet al. Beta-blockade during and after myocardialinfarction an overview of the randomized trials[ J]. Prog Cardiovasc Dis,1985;27(5):335-71.
4Wikstrand J, Berglund G, Hedblad B, et al. Antiatherosclerotic effects ofbeta-blockers[ J]. Am J Cardiol,2003;91(suppl):25-9.
5Anzai T, Yoshikawa T, Takahashi T,et al. Early use of beta-blockers isassociated with attenuation of serum c-reactive protein elevation and fa-vorable short-term prognosis after acute myocardial infarction[ J]. Cardi-ology ,2003;99:47-53.
6Olsson G,Rehnqvist N. Long-term with metoprolol after myocardial in-farction effect on 3 year mortality and morbidity [ J ]. J Am Coll Cardiol,1985;5(6):1428-37.
7Olsson G,Rehnqvist N. Reduction of nonfatal reinfarctions in patientswith a history of hypertension by chronic postinfarction treatment withmetoprolol[ J]. Acta Med Scand, 1986;220(1 ):33-8.
8First International Study of Infarct Survival Collaborative Group. Ran-domised trial of intravenous atenolol among 16027 cases of suspected a-cute myocardial infarction:ISIS-1[J]. Lancet, 1986;2(8498):57-66.
9The MIAMI Trial Research Group. Metoprolol in acute myocardial in-farction(MIAMI):a randomised placebo-controlled International trial[J]. Eur Heart J,1985;6(3):199-226.
10The MIAMI Trial Research Group. Metoprolol in acute myocardial in-farction(MIAMI):narcotic analgesics and other antianginal drugs(J].Am J Cardiol, 1985;56(14):30G-40G.
